
Eltrombopag 50 mg (Rebopag) is a prescription medicine used to treat low platelet counts, also known as thrombocytopenia, caused by certain blood disorders. It is commonly prescribed for chronic immune thrombocytopenia (ITP), severe aplastic anaemia, and selected patients with hepatitis C-associated thrombocytopenia. It helps the body produce more platelets, reducing the risk of bleeding and supporting normal blood clotting.
| Generic name | Eltrombopag |
| Strength | 50 mg |
| Manufacturer | MSN |
| Package size | 28 Tablets |
| Used for | Low blood platelet counts (thrombocytopenia) and severe aplastic anemia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Eltrombopag is a thrombopoietin receptor agonist that stimulates the bone marrow to produce more platelets. This increases the platelet count in the bloodstream, helping improve blood clotting and reduce the risk of bleeding in patients with thrombocytopenia.
Dr. Rajesh Gupta holds a Doctor of Medicine (MD) degree and has a professional interest in thrombocytopenia, aplastic anemia and related blood disorders. His interests include evaluating low platelet counts, monitoring blood cell levels, supporting appropriate treatment planning and recognising complications such as bleeding, infection and severe fatigue.